| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |